CN Stock MarketDetailed Quotes
300216 Hunan Chinasun Pharmaceutical Machinery
- 0.00
- 0.000.00%
Trading Sep 18 09:30 CST
0Market Cap0.00P/E (TTM)
0.00High0.00Low0lotVolume0.00Open0.00Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)361.43MShares0.2152wk High0.00P/B0Float Cap0.1752wk Low0.00Limit Up291.68MShs Float76.29Historical High0.00Limit Down0.00%Amplitude0.17Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Hunan Chinasun Pharmaceutical Machinery Key Stats
All
YOY
| (Q3)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q9)Sep 30, 2019 | (Q6)Jun 30, 2019 | (Q3)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q9)Sep 30, 2018 | (Q6)Jun 30, 2018 | (Q3)Mar 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -2.97%42.37M | -46.65%96.53M | -37.04%157.8M | -49.84%96.87M | -62.06%43.67M | -29.44%180.94M | 13.18%250.63M | -13.66%193.13M | -12.10%115.09M | 12.69%256.42M |
| Refunds of taxes and levies | ---- | -95.39%691.81K | -97.07%636.52K | -85.51%636.52K | -86.42%307.29K | 885.76%15M | 1,329.09%21.74M | 816.06%4.39M | 16,033.36%2.26M | -25.58%1.52M |
| Cash received relating to other operating activities | -43.93%2.75M | -81.67%31.17M | -72.86%33.92M | -95.88%4.71M | -94.60%4.9M | -46.89%170M | -58.15%124.99M | -57.04%114.33M | -29.84%90.69M | -58.66%320.11M |
| Cash inflows from operating activities | -7.68%45.12M | -64.92%128.38M | -51.59%192.36M | -67.22%102.21M | -76.51%48.87M | -36.69%365.94M | -23.82%397.36M | -36.40%311.86M | 49.60%208.04M | -42.42%578.05M |
| Goods services cash paid | 34.50%24.59M | -74.24%17.29M | -26.56%93.87M | -49.54%46.53M | -64.18%18.28M | -66.41%67.11M | -34.62%127.82M | -55.18%92.22M | -47.51%51.05M | 3.13%199.77M |
| Staff behalf paid | -22.71%10.42M | -7.94%61.37M | -1.13%51.68M | -21.13%25.16M | -21.20%13.48M | -43.66%66.66M | -39.14%52.27M | -44.54%31.9M | -46.40%17.11M | 8.27%118.32M |
| All taxes paid | 20.33%2.48M | -26.68%9.61M | -26.63%7.12M | -45.68%4.57M | -31.30%2.06M | -91.99%13.1M | -92.46%9.71M | -91.61%8.41M | -93.75%3.01M | 46.92%163.56M |
| Cash paid relating to other operating activities | -64.88%5.65M | -72.21%38.11M | -60.60%39.01M | -70.69%27.64M | -68.99%16.1M | -91.32%137.14M | -92.67%99.01M | -90.60%94.3M | -90.35%51.93M | 130.18%1.58B |
| Cash outflows from operating activities | -13.58%43.15M | -55.50%126.38M | -33.63%191.68M | -54.20%103.9M | -59.43%49.93M | -86.22%284.02M | -83.59%288.81M | -83.40%226.83M | -48.43%123.09M | 87.29%2.06B |
| Net cash flows from operating activities | 285.81%1.97M | -97.55%2.01M | -99.38%675.73K | -101.98%-1.68M | -101.25%-1.06M | 105.52%81.92M | 108.76%108.55M | 109.70%85.03M | 118.67%84.95M | -1,434.85%-1.48B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | --5.66M | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | --1.17M | 1,237.75%1.16M | ---- | --963.51K | ---- | 40.69%86.98K | ---- | ---- | -99.56%361.27K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | 1,237.75%1.16M | ---- | ---- | ---- | --86.98K | ---- | ---- |
| Cash received relating to other investing activities | ---- | 517.64%4.75M | --4.75M | --4.75M | ---- | -99.54%768.9K | ---- | ---- | ---- | --166.97M |
| Cash inflows from investing activities | ---- | -8.01%5.92M | 6,697.95%5.91M | 6,697.95%5.91M | --963.51K | -96.16%6.43M | -99.95%86.98K | -99.95%86.98K | ---- | 106.01%167.33M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -83.14%579.91K | 83.50%10.28M | -54.84%7.43M | 5.11%6.49M | -37.62%3.44M | -96.95%5.6M | -90.86%16.46M | -94.73%6.17M | -93.03%5.51M | -57.10%183.52M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -89.87%997.11K |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --321.27K | ---- | ---- | ---- |
| Cash outflows from investing activities | -83.14%579.91K | 83.50%10.28M | -55.71%7.43M | 5.11%6.49M | -37.62%3.44M | -96.96%5.6M | -90.73%16.78M | -94.78%6.17M | -95.91%5.51M | -58.78%184.52M |
| Net cash flows from investing activities | 76.57%-579.91K | -624.47%-4.36M | 90.89%-1.52M | 90.51%-577.6K | 55.10%-2.48M | 104.84%831.35K | -19.40%-16.7M | -112.50%-6.09M | 95.91%-5.51M | 95.31%-17.18M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 150.00%500K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 150.00%500K |
| Cash from borrowing | ---- | -99.29%60K | ---- | ---- | ---- | -99.63%8.5M | -99.54%8.5M | ---- | ---- | 47.73%2.28B |
| Cash inflows from financing activities | ---- | -99.29%60K | ---- | ---- | ---- | -99.63%8.5M | -99.54%8.5M | ---- | ---- | 32.31%2.28B |
| Borrowing repayment | --193.69K | -77.29%3.19M | -79.78%2.59M | -76.64%2.57M | ---- | -98.64%14.03M | -98.50%12.79M | -98.23%11.01M | -98.88%5.02M | 9.42%1.03B |
| Dividend interest payment | 13.99%50.95K | -90.94%3.17M | -98.75%490.74K | -98.22%449.34K | -99.78%44.69K | -81.32%34.98M | -69.64%39.41M | -61.48%25.2M | -35.91%20.38M | 90.30%187.21M |
| Cash payments relating to other financing activities | ---- | ---- | ---- | ---- | ---- | -7.88%123.43M | 14.65%123.35M | 1,859.97%123.35M | --124.55M | 3,728.52%134M |
| Cash outflows from financing activities | 447.37%244.64K | -96.32%6.35M | -98.25%3.08M | -98.11%3.02M | -99.97%44.69K | -87.28%172.44M | -83.92%175.55M | -77.04%159.56M | -68.71%149.95M | 29.45%1.36B |
| Net cash flows from financing activities | -447.37%-244.64K | 96.16%-6.29M | 98.16%-3.08M | 98.11%-3.02M | 99.97%-44.69K | -117.77%-163.94M | -121.55%-167.05M | -125.76%-159.56M | -198.52%-149.95M | 36.75%922.36M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 163.96%69.25K | -64.26%73.29K | 1,356.65%135.74K | 62.62%-4.93K | -832.00%-108.27K | 175.28%205.06K | 116.00%9.32K | 88.83%-13.2K | 883.60%14.79K | 50.61%-272.39K |
| Net increase in cash and cash equivalents | 132.90%1.21M | 89.41%-8.57M | 94.96%-3.79M | 93.44%-5.29M | 94.77%-3.69M | 85.99%-80.99M | 84.25%-75.19M | 61.27%-80.63M | 81.56%-70.5M | -374.14%-578.24M |
| Add:Begin period cash and cash equivalents | -40.08%12.81M | -79.11%21.39M | -79.13%21.39M | -79.13%21.39M | -79.13%21.39M | -84.96%102.37M | -84.95%102.46M | -84.95%102.46M | -84.95%102.46M | 44.91%680.61M |
| End period cash equivalent | -20.75%14.03M | -40.08%12.81M | -35.47%17.6M | -26.26%16.1M | -44.63%17.7M | -79.11%21.39M | -86.57%27.28M | -95.38%21.83M | -89.29%31.96M | -84.96%102.37M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Disclaimer of Opinion | -- | -- | -- | Disclaimer of Opinion | -- | -- | -- | Disclaimer of Opinion |
| Auditor | -- | Leanda Certified Public Accountants (Special General Partnership) | -- | -- | -- | Leanda Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ruihua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data